WHIP 131

Drug Profile

WHIP 131

Alternative Names: DDE 9501; WHI P131

Latest Information Update: 10 Sep 2003

Price : $50

At a glance

  • Originator Wayne Hughes Institute
  • Class Anti-inflammatories
  • Mechanism of Action Apoptosis stimulants; Collagen inhibitors; Janus kinase 3 inhibitors; Mast cell inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Allergic asthma; Amyotrophic lateral sclerosis; Cancer; Graft-versus-host disease; Skin disorders; Thromboembolism; Thrombosis

Most Recent Events

  • 17 Sep 2001 Preclinical development for Graft-versus-host disease in USA (Unknown route)
  • 05 Apr 2001 A preclinical study has been added to the Thromboses pharmacodynamics section
  • 05 Apr 2001 Preclinical development for Thrombosis in USA (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top